Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nanologica AB (DE:4YD)
FRANKFURT:4YD
Holding DE:4YD?
Track your performance easily
4YD Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.12 - €0.92
Previous Close€0.12
Volume0.00
Average Volume (3M)75.00
Market Cap
€13.07M
Enterprise Value€7.40M
Total Cash (Recent Filing)kr70.32M
Total Debt (Recent Filing)kr4.69M
Price to Earnings (P/E)―
Beta-0.48
Next Earnings
Feb 07, 2025EPS Estimate
>-€0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume75
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)164.12
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Nanologica AB News
PremiumPre-Earnings
Is 4YD a Buy, Before Earnings?4YD FAQ
What was Nanologica AB’s price range in the past 12 months?
Nanologica AB lowest stock price was €0.12 and its highest was €0.92 in the past 12 months.
What is Nanologica AB’s market cap?
Currently, no data Available
When is Nanologica AB’s upcoming earnings report date?
Nanologica AB’s upcoming earnings report date is Feb 07, 2025 which is in 75 days.
How were Nanologica AB’s earnings last quarter?
Nanologica AB released its earnings results on Oct 25, 2024. The company reported -€0.026 earnings per share for the quarter, missing the consensus estimate of -€0.017 by -€0.009.
Is Nanologica AB overvalued?
According to Wall Street analysts Nanologica AB’s price is currently Overvalued.
Does Nanologica AB pay dividends?
Nanologica AB does not currently pay dividends.
What is Nanologica AB’s EPS estimate?
Nanologica AB’s EPS estimate is >-€0.01.
How many shares outstanding does Nanologica AB have?
Nanologica AB has 82,602,210 shares outstanding.
What happened to Nanologica AB’s price movement after its last earnings report?
Nanologica AB reported an EPS of -€0.026 in its last earnings report, missing expectations of -€0.017. Following the earnings report the stock price went up 5%.
Which hedge fund is a major shareholder of Nanologica AB?
Currently, no hedge funds are holding shares in DE:4YD
---
Nanologica AB Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-84.79%
12-Months-Change
Fundamentals
Return on Equity
-688.19%
Trailing 12-Months
Asset Growth
-12.94%
Trailing 12-Months
Company Description
Nanologica AB
Nanologica AB develops and manufactures nanoporous silica particles for life science applications. It focuses on two areas: Drug Development and Chromatography. The company's drug delivery platforms are NLAB Spiro and NLAB Silica, which aim to produce better medicines for the benefit of patients. Its geographical segments are Sweden, China, the United States, and the Rest of the world.
---
Technical Analysis
---